Skip to content
- Dr. Oz Discusses Breakthroughs in AD ResearchNJ.com
- Fujirebio Submits FDA Regulatory Application for Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test as an Aid in Identifying Patients with Amyloid Pathology Associated with Alzheimer’s DiseaseBiospace
- Blood microRNAs may predict the conversion of mild cognitive impairment to dementia due to Alzheimer’s diseaseNews-Medical.Net
- Mount Sinai Health System is the first in the Northeast to use blood testing as a tool for early detection of Alzheimer’s disease and related dementias in patientsMount Sinai
- Serum protein patterns are associated with future diagnosis of Alzheimer’s diseaseNature.com
